Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A medicine for treating allergic rhinitis

A technology for allergic rhinitis and medicament, applied in the field of pharmaceutical preparations, can solve problems such as toxic and side effects, cure the symptoms but not the root cause, human body damage, etc., and achieve the effects of convenient administration, alleviation of rhinothiazide, and significant curative effect.

Active Publication Date: 2016-07-27
周君刚
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinically, anti-inflammatory drugs and antibiotics are mainly used. Anti-inflammatory drugs are only superficial treatment, and antibiotics are restrictive drugs. Although some chemical drugs with good curative effect and quick effect have been developed on the market, due to long-term treatment of patients, it is inevitable. The occurrence of toxic and side effects of rhinitis, causing human injury, mostly treat the symptoms but not the root cause, making the majority of patients miserable. Therefore, the treatment of allergic rhinitis is a long-term treatment, and an effective traditional Chinese medicine preparation is needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] A medicament for treating allergic rhinitis of the present invention comprises 5 g of coptis, 4 g of cocklebur, 6 g of licorice, 3 g of bezoar and 0.12 g of chlorpheniramine.

[0009] Below by clinical observation test, further set forth the beneficial effect of the present invention:

[0010] 1. The medicament of the present invention treats 100 cases of allergic rhinitis patients, 50 men and 50 women, aged from 10 to 70 years old. Clinical symptoms: Allergic symptoms caused by pollen, smoke, pesticides, chemical fertilizers, cold air, air conditioners and irritating odors may cause headache, heavy head, nasal itch, purulent or clear nasal discharge, shoulder pain and pressure on the head , Conscious general weakness, loss of smell or decrease.

[0011] 2. How to take it

[0012] 1 capsule 0.604g each time, 3 times a day, ten days as a course of treatment, 2-3 courses of treatment for mild cases, 3-4 courses of treatment for severe cases.

[0013] 3. Standard of tre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating the allergic rhinitis. The medicament is prepared from the following raw materials: 5 g of coptis, 4 g of xanthium strumarium, 6 g of licorice, 3 g of bezoar, and 0.12 g of chlortrimeton, and prepared by crushing the raw materials in the formula, mixing uniformly, filling the mixture in capsules to be taken, or preparing to tablets or other dosage forms. As the medicament disclosed by the invention is prepared by the mixture of Chinese herbs and western medicine, the medicament can alleviate the symptoms of rhinitis and further cure the disease, quickly remove inflammation and allergen in the nasal cavity, rapidly relieve symptoms of nasal congestion and running nose, and gradually improve sense of smell; the medicament is low in cost, effective in treatment, and convenient to take.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a medicament for treating allergic rhinitis. Background technique [0002] Allergic rhinitis often occurs throughout the year. The clinical manifestations are clear nasal discharge, nasal itching, sneezing, nasal mucosal edema, and paleness. It is a common and frequently-occurring disease in clinical practice, and its incidence rate can reach about 5%. Seriously affect people's life and work. The disease is affected by specific and non-specific factors, restricted by the environment and other factors, which directly affect the curative effect of the disease. Therefore, clinically, it is only said to control the disease, but not to cure it. a term. Clinically, anti-inflammatory drugs and antibiotics are mainly used. Anti-inflammatory drugs are only superficial treatment, and antibiotics are restrictive drugs. Although some chemical drugs with good curative effect and qu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/718A61P37/08A61P11/02A61K31/4402A61K35/413
CPCA61K9/48A61K31/4402A61K35/413A61K36/28A61K36/484A61K36/718A61K2300/00
Inventor 周君刚
Owner 周君刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products